Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06239571 · ClinicalTrials.gov registry record · NA
Resilient Families Open Pilot: Dyadic Resiliency Intervention
A NA study of Parents, sponsored by Massachusetts General Hospital.
- Active
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT06239571: Active NA study of Parents, sponsored by Massachusetts General Hospital.
NCT06239571 is a NA study of Parents that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 10 participants, below the 297-participant average among 14 other Parents trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06239571, a NA study of Parents, is active but no longer recruiting, sponsored by Massachusetts General Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal is to develop, refine, and test the feasibility and acceptability of a dyadic, resiliency intervention ("Resilient Families;" R-FAM) that aims to reduce emotional distress and improve relationships among parents in the Neonatal Intensive Care Unit (NICU). To achieve this goal, my aims are three-fold: (1) develop R-FAM using stakeholder input from interviews with parent dyads and focus groups with NICU staff; (2) optimize R-FAM through an open pilot with pre/post assessments and exit interviews; and (3) test R-FAM for feasibility and acceptability through a randomized clinical trial of R-FAM compared with a minimally enhanced usual control (MEUC).
Primary Outcome
Level of depression endorsed on Hospital Anxiety \& Depression Scale and Edinburgh Postnatal Depression Scale, from 0-30 with 30 indicating highest depression
Conditions Studied
Interventions
- BEHAVIORAL Resilient Families (R-FAM)
Study Locations (1)
Massachusetts
- Mass General Brigham - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-05-08 |
| Est. Completion | 2028-03-31 |
| Phase | NA |
What the registry record for NCT06239571 still lists
NCT06239571 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 297-participant average among 14 other Parents trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Parents appearing as the primary indexed condition, and to 1 intervention - of which Resilient Families (R-FAM) is the first listed.
NCT06239571 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06239571 about?
NCT06239571 is a clinical study titled "Resilient Families Open Pilot: Dyadic Resiliency Intervention". The goal is to develop, refine, and test the feasibility and acceptability of a dyadic, resiliency intervention ("Resilient Families;" R-FAM) that aims to reduce emotional distress and improve relationships among parents in the Neonatal Intensive Care Unit (NICU). To achieve this goal, my aims are t...
What is the current status of trial NCT06239571?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2025-05-08. Estimated completion is 2028-03-31.
What conditions does trial NCT06239571 study?
This clinical trial studies the following conditions: Parents.
What interventions are being tested in trial NCT06239571?
The interventions under investigation include: Resilient Families (R-FAM) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06239571?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06239571 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parents
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06239571's enrollment target sits among peer trials
10 14th of 14 the lowest of 14 other Parents trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Parents trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Text-messaging Intervention to Support Parents After Their Child's Psychiatric Emergency
RECRUITING · NA
-
Sensory Optimization of the Hospital Environment
RECRUITING · NA
-
ACT Together: Implementing a Web-Based Program With Brief Coaching for Parents of Children With Disabilities in Pediatric Outpatient Clinics
RECRUITING · NA
-
HomeStyles-2: Shaping HOME Environments and LifeSTYLES to Prevent Childhood Obesity
RECRUITING · NA
-
Group CBT in Parents of Children With Food Allergy
RECRUITING · NA
-
Father-Inclusive Parenting Intervention in Mwanza, Tanzania
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI